Laser lithotripsy devices market seen rising to $4.04B by 2030

The laser lithotripsy devices market is projected to grow from $2.4 billion in 2025 to $2.67 billion in 2026, with longer-term growth expected to reach $4.04 billion by 2030. The report points to rising kidney disease, more minimally invasive procedures, and new laser technologies as the main drivers.

Why it matters: - Laser lithotripsy devices are becoming a more common option for treating kidney and urinary tract stones because they offer a minimally invasive and precise alternative to traditional surgery. - The market’s projected growth signals sustained demand for urology devices as stone disease and kidney-related conditions continue to rise.

What happened: - The Business Research Company published a 2026 market report on laser lithotripsy devices covering market size, trends, and global forecast to 2035. - The market is projected to rise from $2.4 billion in 2025 to $2.67 billion in 2026. - That 2025-to-2026 increase implies 11.3% compound annual growth. - The market is expected to reach $4.04 billion by 2030, based on a 10.9% CAGR. - North America was the largest regional market in 2025. - Asia-Pacific is expected to be the fastest-growing region during the forecast period.

The details: - Laser lithotripsy devices use laser energy to break kidney and urinary tract stones into smaller fragments. - The smaller fragments are easier to pass or remove. - The technique reduces the risk of damaging surrounding tissue compared with traditional surgical methods. - Historical growth has been supported by limited access to advanced laser systems, reliance on conventional stone-removal surgery, rising stone prevalence, expansion of hospital urology departments, and early adoption of holmium YAG laser technology. - Looking ahead, growth is expected to be supported by thulium fiber laser technology, more outpatient surgical facilities, and tighter integration with digital imaging and navigation systems. - The report also points to rising research and development investment in urology device innovation. - Other expected trends include more portable lithotripsy devices, demand for higher-powered and more efficient lasers, growth in ambulatory surgical centers, and improved laser safety and patient monitoring. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. - The report also adds market attractiveness scoring, total addressable market analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technologies and future trend analysis, and updated graphics and tables. - A free sample report is available here. - The full report is available here.

Between the lines: - The forecast suggests the market is moving from a niche device category toward broader clinical adoption as hospitals and outpatient centers look for faster, less invasive stone treatment. - The emphasis on portable systems, imaging integration, and patient monitoring points to competition shifting beyond core laser performance. - Kidney disease prevalence remains a key demand driver because chronic kidney disease and stone-related conditions increase the need for repeat interventions and better treatment tools. - Kidney Research UK reported in June 2023 that about 7.19 million people in the UK were living with chronic kidney disease in 2023, equal to more than 10% of the population. - Kidney Research UK expects that number to reach 7.61 million by 2033.

What's next: - Market growth is likely to track adoption of newer laser platforms, especially thulium fiber systems. - Growth in ambulatory surgical centers and outpatient procedures should continue to support device demand. - Regional momentum is likely to stay strongest in North America and Asia-Pacific, with Asia-Pacific benefiting from faster expansion. - More investment in imaging-linked and safety-focused systems could shape the next competitive phase.